Mostly Cloudy 74°
Tag:

Magenta Therapeutics

Business
Death In Cambridge Clinical Trial May Spell End Of Biotech Company Death In Cambridge Clinical Trial May Spell End Of Biotech Company
Death In Cambridge Clinical Trial May Spell End Of Biotech Company Just two weeks after announcing the death of a participant in a clinical trial, a Cambridge biotech company announced it would stop further development of its programs.  Magenta Therapeutics, which focuses on using stem cell transplantation to treat blood cancers, genetic diseases, and autoimmune diseases, announced on Wednesday, Jan. 25 that the latest patient to be dosed with their MGTA-117 drug, which depletes stem cells to make room in the bone marrow for stem cell transportation, died after experiencing respiratory failure and cardiac arrest.  The clinical trial for the MGTA-117 drug …

SHARE

by Morgan Gonzales